CYCN
Price
$2.59
Change
-$0.06 (-2.26%)
Updated
Aug 1 closing price
Capitalization
9.24M
HRTX
Price
$1.69
Change
-$0.04 (-2.31%)
Updated
Aug 1 closing price
Capitalization
257.07M
8 days until earnings call
Interact to see
Advertisement

CYCN vs HRTX

Header iconCYCN vs HRTX Comparison
Open Charts CYCN vs HRTXBanner chart's image
Cyclerion Therapeutics
Price$2.59
Change-$0.06 (-2.26%)
Volume$21.47K
Capitalization9.24M
Heron Therapeutics
Price$1.69
Change-$0.04 (-2.31%)
Volume$1.02M
Capitalization257.07M
CYCN vs HRTX Comparison Chart in %
Loading...
CYCN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYCN vs. HRTX commentary
Aug 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYCN is a Hold and HRTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 03, 2025
Stock price -- (CYCN: $2.59 vs. HRTX: $1.69)
Brand notoriety: CYCN and HRTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYCN: 54% vs. HRTX: 83%
Market capitalization -- CYCN: $9.24M vs. HRTX: $257.07M
CYCN [@Biotechnology] is valued at $9.24M. HRTX’s [@Biotechnology] market capitalization is $257.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $213.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYCN’s FA Score shows that 1 FA rating(s) are green whileHRTX’s FA Score has 0 green FA rating(s).

  • CYCN’s FA Score: 1 green, 4 red.
  • HRTX’s FA Score: 0 green, 5 red.
According to our system of comparison, CYCN is a better buy in the long-term than HRTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYCN’s TA Score shows that 3 TA indicator(s) are bullish while HRTX’s TA Score has 4 bullish TA indicator(s).

  • CYCN’s TA Score: 3 bullish, 6 bearish.
  • HRTX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, HRTX is a better buy in the short-term than CYCN.

Price Growth

CYCN (@Biotechnology) experienced а -9.31% price change this week, while HRTX (@Biotechnology) price change was -11.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.14%. For the same industry, the average monthly price growth was +15.55%, and the average quarterly price growth was +36.18%.

Reported Earning Dates

CYCN is expected to report earnings on May 06, 2025.

HRTX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+0.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HRTX($257M) has a higher market cap than CYCN($9.24M). HRTX YTD gains are higher at: 10.458 vs. CYCN (-19.453). HRTX has higher annual earnings (EBITDA): 2.76M vs. CYCN (-3.47M). HRTX has more cash in the bank: 50.7M vs. CYCN (3.64M). CYCN has less debt than HRTX: CYCN (0) vs HRTX (177M). HRTX has higher revenues than CYCN: HRTX (149M) vs CYCN (2.08M).
CYCNHRTXCYCN / HRTX
Capitalization9.24M257M4%
EBITDA-3.47M2.76M-126%
Gain YTD-19.45310.458-186%
P/E RatioN/AN/A-
Revenue2.08M149M1%
Total Cash3.64M50.7M7%
Total Debt0177M-
FUNDAMENTALS RATINGS
CYCN vs HRTX: Fundamental Ratings
CYCN
HRTX
OUTLOOK RATING
1..100
7950
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
65
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
8988
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CYCN's Valuation (19) in the null industry is somewhat better than the same rating for HRTX (65) in the Biotechnology industry. This means that CYCN’s stock grew somewhat faster than HRTX’s over the last 12 months.

CYCN's Profit vs Risk Rating (100) in the null industry is in the same range as HRTX (100) in the Biotechnology industry. This means that CYCN’s stock grew similarly to HRTX’s over the last 12 months.

CYCN's SMR Rating (96) in the null industry is in the same range as HRTX (100) in the Biotechnology industry. This means that CYCN’s stock grew similarly to HRTX’s over the last 12 months.

HRTX's Price Growth Rating (88) in the Biotechnology industry is in the same range as CYCN (89) in the null industry. This means that HRTX’s stock grew similarly to CYCN’s over the last 12 months.

HRTX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as CYCN (100) in the null industry. This means that HRTX’s stock grew similarly to CYCN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CYCNHRTX
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
82%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 24 days ago
85%
Bullish Trend 26 days ago
83%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
CYCN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASWRF0.02N/A
N/A
Gungnir Resources Inc.
BOSSY9.52N/A
N/A
Hugo Boss AG
KTHN25.00N/A
N/A
Katahdin Bankshares Corp.
SNDVF13.30N/A
N/A
Scandinavian Tob Group AS
ARZGY18.46-0.18
-0.97%
Assicurazioni Generali Spa

CYCN and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYCN has been loosely correlated with HRTX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if CYCN jumps, then HRTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYCN
1D Price
Change %
CYCN100%
-2.13%
HRTX - CYCN
41%
Loosely correlated
-2.31%
GDTC - CYCN
30%
Poorly correlated
-2.66%
FATE - CYCN
29%
Poorly correlated
-2.73%
IBIO - CYCN
25%
Poorly correlated
-3.09%
PALI - CYCN
24%
Poorly correlated
-0.98%
More

HRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, HRTX has been loosely correlated with GSGTF. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if HRTX jumps, then GSGTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HRTX
1D Price
Change %
HRTX100%
-2.31%
GSGTF - HRTX
45%
Loosely correlated
N/A
AMRN - HRTX
44%
Loosely correlated
+4.41%
CYCN - HRTX
39%
Loosely correlated
-2.13%
ACAD - HRTX
38%
Loosely correlated
-1.26%
AXON - HRTX
38%
Loosely correlated
-1.72%
More